Clinical Trial Update: Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine [Phase 2]

View source ↗

Summary

Phase 2 monocentric pilot trial assessing metabolic activity of melanoma in vivo during treatment with sorafenib and dacarbazine; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Sorafenib (Sorafenib)

Snippet

Sponsor: University of Zurich | Conditions: Melanoma Stage III or IV, No Prior Chemotherapy | Phase 2 | Status: COMPLETED